For citations:
Nikolaeva A.M., Ivanov A.V., Smolyanova T.I., Razumikhin M.V., Belyakova O.V., Shilova E.G., Selezneva N.R., Vyaznikova T.V., Semicheva A.I., Sakanyan E.I. Preclinical Evaluation of a New Anti-COVID-19 Intravenous Immunoglobulin. Drug development & registration. 2023;12(1):155-160. (In Russ.) https://doi.org/10.33380/2305-2066-2023-12-1-155-160
Email this article 